Duane A. Burnett
Ark Therapeutic (United States)(US)C4 Therapeutics (United States)(US)
Publications by Year
Research Areas
Synthesis of β-Lactam Compounds, Synthesis and Catalytic Reactions, Receptor Mechanisms and Signaling, Cholinesterase and Neurodegenerative Diseases, Protease and Inhibitor Mechanisms
Most-Cited Works
- → The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)(2005)763 cited
- → Discovery of 1-(4-Fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)- hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption(1998)353 cited
- → 2-Azetidinones as Inhibitors of Cholesterol Absorption(1994)238 cited
- → The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption(2002)160 cited
- → Pyrrolizidinone and indolizidinone synthesis: generation and intramolecular addition of .alpha.-acylamino radicals to olefins and allenes(1984)146 cited
- → β-Lactam Cholesterol Absorption Inhibitors(2004)137 cited